💊📈 Check out our latest #pharmacoepi study on the Risk of Intraocular Pressure Increase With #Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors published on American Journal of Ophthalmology. The results of our study are suggestive of an increased risk of #IOP increase in non-diabetic patients using #bevacizumab and #ranibizumab compared with #aflibercept users

#AntiVEGF #eye #pharmacoepidemiology

https://www.sciencedirect.com/science/article/abs/pii/S0002939422004408